Analysis of intracellular didanosine triphosphate at sub-ppb level using LC-MS/MS

Citation
X. Cahours et al., Analysis of intracellular didanosine triphosphate at sub-ppb level using LC-MS/MS, J PHARM B, 26(5-6), 2001, pp. 819-827
Citations number
13
Categorie Soggetti
Chemistry & Analysis
Journal title
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
ISSN journal
07317085 → ACNP
Volume
26
Issue
5-6
Year of publication
2001
Pages
819 - 827
Database
ISI
SICI code
0731-7085(200112)26:5-6<819:AOIDTA>2.0.ZU;2-Y
Abstract
An analytical procedure has been developed for the analysis of intracellula r didanosine triphosphate (ddATP). An electrospray ionization tandem mass s pectrometer (ESI-MS) was interfaced to liquid chromatography (LC) using a m obile phase CH3OH/H2O (25/75) containing 1% formic acid for the analysis of the 5'-triphosphate metabolite of the antiviral didanosine. In this proced ure. ddATP was extracted from CEM-T4 cells, isolated using an exchange anio n solid phase extraction procedure, enzymatically dephosphorylated and then analyzed by LC-MS/MS within a I min run time. The influence of several par ameters (electrospray ionization interface, acidic modifiers of the mobile phase) has been studied. A calibration curve was generated and the linear r egression analysis yielded a regression coefficient (r(2)) greater than 0.9 99. Using LC-MS/MS detection in single reaction monitoring mode (SRM), the limit of quantitation of ddA in CEM-T4 cells was 0.02 ng ml(-1). Furthermor e, this procedure could be used to perform simultaneous detection of five n ucleoside reverse transcriptase inhibitors, such as AZT, 3TC. ddA, ddC and d4T and make LC-MS/MS a method of choice for Therapeutic Drug Monitoring (T DM) in a clinical environment. (C) 2001 Elsevier Science B.V. All rights re served.